UMN Pharma Inc. 4585Short Interest
No institution currently reports a short position of 0.5% or more in UMN Pharma Inc. (4585). The last disclosure was on 2019-10-15 (Credit Suisse Securities (Europe) Limited, 0.46%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
72 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 4 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-11-02 |
|---|---|
| Latest disclosure | 2019-10-15 (Credit Suisse Securities (Europe) Limited, 0.46%) |
| Reporting institutions | 5 firms (72 reports) |
| Peak estimated short interest | 2.69% (2018-02-05, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
No position of 0.5% or more reported within a year existed in the last 5 years, so no chart is shown. Past disclosures are listed in the tables below.
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2017-12-07 | JPM Securities Japan Co Ltd. | Position 63,400 shares | Ratio 0.49% | ▼0.09% | Below 0.5% |
| 2018-06-07 | Nomura International plc | Position 62,700 shares | Ratio 0.48% | ▼0.19% | Below 0.5% |
| 2019-07-31 | UBS AG | Position 72,300 shares | Ratio 0.47% | ▼0.11% | Below 0.5% |
| 2019-10-15 | Credit Suisse Securities (Europe) Limited | Position 81,545 shares | Ratio 0.46% | ▼0.07% | Below 0.5% |
| 2017-11-02 | スパークス・アセット・マネジメント株式会社 | Position 0 shares | Ratio 0.00% | ▼0.60% | Closed |
Disclosure History 72 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2019-10-15 | Credit Suisse Securities (Europe) Limited | Position 81,545 shares | Ratio 0.46% | ▼0.07% | Below 0.5% |
| 2019-10-11 | Credit Suisse Securities (Europe) Limited | Position 94,045 shares | Ratio 0.53% | ▲0.09% | — |
| 2019-07-31 | UBS AG | Position 72,300 shares | Ratio 0.47% | ▼0.11% | Below 0.5% |
| 2019-07-26 | UBS AG | Position 89,800 shares | Ratio 0.58% | ▼0.08% | — |
| 2019-07-23 | UBS AG | Position 101,200 shares | Ratio 0.66% | ▼0.11% | — |
| 2019-07-17 | UBS AG | Position 118,000 shares | Ratio 0.77% | ▼0.03% | — |
| 2019-07-11 | UBS AG | Position 123,500 shares | Ratio 0.80% | ▲0.01% | — |
| 2019-07-09 | UBS AG | Position 121,800 shares | Ratio 0.79% | ▼0.09% | — |
| 2019-07-05 | UBS AG | Position 134,700 shares | Ratio 0.88% | ▼0.10% | — |
| 2019-07-03 | UBS AG | Position 150,500 shares | Ratio 0.98% | ▼0.04% | — |
| 2019-07-02 | UBS AG | Position 157,400 shares | Ratio 1.02% | ▼0.16% | — |
| 2019-06-28 | UBS AG | Position 181,400 shares | Ratio 1.18% | ▼0.09% | — |
| 2019-06-26 | UBS AG | Position 195,700 shares | Ratio 1.27% | ▼0.10% | — |
| 2019-06-20 | UBS AG | Position 210,300 shares | Ratio 1.37% | ▼0.11% | — |
| 2019-06-17 | UBS AG | Position 226,700 shares | Ratio 1.48% | ▼0.11% | — |
| 2019-06-11 | UBS AG | Position 244,500 shares | Ratio 1.59% | ▼0.10% | — |
| 2019-06-05 | UBS AG | Position 259,200 shares | Ratio 1.69% | ▼0.02% | — |
| 2019-05-23 | UBS AG | Position 262,200 shares | Ratio 1.71% | ▲0.40% | — |
| 2019-05-15 | UBS AG | Position 200,900 shares | Ratio 1.31% | ▲0.09% | — |
| 2019-04-25 | UBS AG | Position 187,400 shares | Ratio 1.22% | ▲0.03% | — |
| 2019-04-24 | UBS AG | Position 182,100 shares | Ratio 1.19% | ▼0.01% | — |
| 2019-04-23 | UBS AG | Position 184,100 shares | Ratio 1.20% | ▲0.07% | — |
| 2019-04-18 | UBS AG | Position 172,900 shares | Ratio 1.13% | ▲0.05% | — |
| 2019-04-17 | UBS AG | Position 165,500 shares | Ratio 1.08% | ▲0.15% | — |
| 2019-04-16 | UBS AG | Position 143,500 shares | Ratio 0.93% | ▲0.24% | — |
| 2019-04-12 | UBS AG | Position 105,600 shares | Ratio 0.69% | ▲0.37% | — |
| 2018-12-11 | Credit Suisse Securities (Europe) Limited | Position 75,228 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2018-11-26 | Credit Suisse Securities (Europe) Limited | Position 91,528 shares | Ratio 0.59% | ▼0.03% | — |
| 2018-11-21 | Credit Suisse Securities (Europe) Limited | Position 95,028 shares | Ratio 0.62% | ▼0.17% | — |
| 2018-10-02 | Credit Suisse Securities (Europe) Limited | Position 102,128 shares | Ratio 0.79% | ▼0.09% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| Otsuka Holdings Co.,Ltd.4578 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Large70 |
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| PeptiDream Inc.4587 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| RIBOMIC Inc.4591 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |